WuHan Dong Kang Yuan Technology co., LTD

 

Integrity-based service-oriented Kangyuan products must be boutiques.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsCaine Series Pharma Raw Materials

Lidocaine Hydrochloride Pharma Raw Materials For Anesthesia

Lidocaine Hydrochloride Pharma Raw Materials For Anesthesia

Lidocaine Hydrochloride Pharma Raw Materials For Anesthesia
Lidocaine Hydrochloride Pharma Raw Materials For Anesthesia

Large Image :  Lidocaine Hydrochloride Pharma Raw Materials For Anesthesia Get Best Price

Product Details:

Place of Origin: China
Brand Name: DKY
Model Number: 73-78-9

Payment & Shipping Terms:

Minimum Order Quantity: 1 KG
Packaging Details: 1kg/bag or 25kg/drum
Delivery Time: 5-7 work days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 200 tons per year
Detailed Product Description
CAS No: 73-78-9 EINECS No: 200-803-8
Molecular Formula: C14H23ClN2O Molecular Weight: 270.7982
Melting Point: 75-79 ℃ PH: 4.0 To 5.5
Moisture: 5.0% 7.5% Incandescent Residue: ≤0.1%
Heavy Metal: ≤10ppm Standard: CP2010; USP
Solubility: Soluble In Water Or Ethanol. The Aqueous Solution Is Stable Under Acid And Alkali, And Rarely Deteriorates After Repeated Autoclave Sterilization. Appearance: White Crystalline Powder, Odorless.
Appearance Description: White Powder Content: 99%
Packing: 25kg/ Cardboard Drum
High Light:

caine series chemicals

,

caine medicine raw material

Lidocaine HCl 73-78-9 Caine Series Pharma Raw Materials used for anesthesia

 

1. Product name :lidocaine

2. Product nickname :2-(dimethylamino-n -(2,6-dimethylphenyl)-acetamide; Lidocaine HCl. Lignocaine HCl. LidocaineHydrochloride; N - (2, 6 - dimethylphenyl) - N ~ 2 ~ N ~ 2 ~ - diethylglycinamide hydrochloride (1:1)

3. CAS: 73-78-9

4. EINECS: 200-803-8

5. Molecular formula: C14H23ClN2O

6. Molecular weight: 270.7982

7. Melting point: 75-79 ℃

8. Ph: 4.0 to 5.5

9. Moisture: 5.0% 7.5%

10. Incandescent residue: ≤0.1%

11. Heavy metal: ≤10ppm

12. Standard: CP2010; USP

13. Solubility: soluble in water

14. Appearance: white crystalline powder, odorless.

15. Solubility: soluble in water or ethanol. The aqueous solution is stable under acid and alkali, and rarely deteriorates 16. after repeated autoclave sterilization.

17. Appearance description: white powder

18. Content: 99%

19. Packing: 25kg/ cardboard drum

 

Certificate of Analysis:

Product Name Lidocaine hydrochloride
Quantity 1kg Batch No. 20200305
MFG. Date 20200305 Analysis Date 20200306
Exp. Date 20200305 Inspection Basis USP35
ITEMS SPECIFICATIONS RESULTS
Appearance White crystalline powder Pass
Content Wt. 99.00%-101.00% 99.92%
Identification Chloridate Positive
  Test A Positive
Melting point 74-79℃ 76-78℃
Appearance of solution Clear and colourless Pass
Water 5.5-7.0% 6.7%
Acidity PH 4.0-5.5 5.2
Sulphated ash 0.10% max 0.08%
Heavy metals 5ppm max Pass
2, 6-Dimethylaniline 100ppm max Pass
Conclusion Qualified

 

Structure:

Lidocaine Hydrochloride Pharma Raw Materials For Anesthesia 0

 

Pharmacological effects:
Convulsions may occur when the blood concentration of the drug exceeds 5 ·ml-1. At a low dose, this product can promote the k+ outflow from cardiomyocytes, reduce the self-discipline of cardiomyocytes, and has an anti-ventricular arrhythmia effect. There was no significant effect on the electrical activity, atrioventricular conduction and myocardial contraction of cardiomyocytes at the therapeutic dose. A further increase in the concentration of the drug may cause a slowing of cardiac conduction velocity, atrioventricular block, inhibition of myocardial contractility, and a decrease in cardiac output.
 
Indications:
It is a local anesthetic and an antiarrhythmic agent. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve block. This product can be used for ventricular premature beats and ventricular tachycardia after acute myocardial infarction, as well as digitalis poisoning, cardiac surgery, and ventricular arrhythmias caused by cardiac catheters. It is usually ineffective against supraventricular arrhythmias.
 
 

Contact Details
WuHan Dong Kang Yuan technology co., LTD

Contact Person: Angela

Tel: 86-15377658509

Send your inquiry directly to us